SCCM Pod-420 Nebulized Bacteriophages for Prophylaxis of Experimental MRSA VAP

Published: Sept. 10, 2020, 2:50 p.m.

Alternative strategies are needed to combat and prevent antibiotic-resistant bacterial infections. Host Ashish K. Khanna, MD, FCCP, FCCM, talks with David R. Cameron, PhD, about the potential for bacteriophage prophylaxis in the context of experimental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.